FMRS Health Systems Inc is a licensed substance use treatment provider in Beckley, WV, listed in the SAMHSA treatment directory. Clients can live on site in a residential program while they complete treatment. An intensive outpatient program lets clients attend structured treatment several days a week while living at home. On site detox services are available, so withdrawal can be managed before treatment begins. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The facility reports accepting Medicaid. Private health insurance is accepted. It serves children/adolescents, young adults, adults.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Substance use treatmentDetoxificationTreatment for co-occurring disorders plus serious mental illness (SMI) in adultsTreatment for co-occurring disorders plus serious emotional disturbance (SED) in children
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Detox services
Alcohol DetoxificationBenzodiazepines DetoxificationOpioids detoxificationMedication routinely used during detoxification
Payment accepted
Federal, or any government funding for substance use treatment programsMedicareMedicaidFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-paymentState-financed health insurance plan other than MedicaidSAMHSA funding/block grants
Ages served
Children/AdolescentsYoung AdultsAdultsSeniors
Accreditation
State department of healthDrug Enforcement Agency (DEA)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
OutpatientOutpatient detoxificationOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsFederal military insurance (e.g., TRICARE)
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicare